CARL
HEALTHCARECarlsmed Inc
$9.84+0.92 (+10.31%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CARL Today?
No stock-specific AI insight has been generated for CARL yet. Check back soon — insights are generated from recent news analysis.
0
Fundamentals
Market Cap$268M
P/E Ratio—
EPS$-0.98
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume247K
Avg Volume (10D)—
Shares Outstanding27.2M
CARL News
20 articles- Here's What Analysts Are Forecasting For Carlsmed, Inc. (NASDAQ:CARL) After Its First-Quarter ResultsYahoo Finance·May 7, 2026
- Carlsmed Q1 Earnings Call HighlightsMarketbeat·May 5, 2026
- Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 5, 2026
- Carlsmed (CARL) Q1 2026 Earnings TranscriptMotley Fool·May 5, 2026
- Carlsmed® Reports First Quarter 2026 Financial ResultsYahoo Finance·May 5, 2026
- Carlsmed, Inc. To Participate in Upcoming Investor ConferencesYahoo Finance·Apr 28, 2026
- Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026Yahoo Finance·Apr 14, 2026
- Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham ConfMarketbeat·Apr 13, 2026
- Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at ConferenceMarketbeat·Mar 7, 2026
- Carlsmed Q4 Earnings Call HighlightsMarketbeat·Feb 26, 2026
- Carlsmed Inc (CARL) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...Yahoo Finance·Feb 26, 2026
- Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 25, 2026
- Carlsmed Announces first corra™ personalized Cervical Plating ProcedureYahoo Finance·Feb 18, 2026
- Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026Yahoo Finance·Feb 11, 2026
- Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion ProcedureYahoo Finance·Feb 10, 2026
- Bullish Carlsmed Insiders Loaded Up On US$8.10m Of StockYahoo Finance·Jan 22, 2026
- Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025Yahoo Finance·Jan 12, 2026
- Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine JournalYahoo Finance·Jan 6, 2026
- CARL Launches Aprevo Cervical Platform for Personalized Spine SurgeryYahoo Finance·Dec 9, 2025
- Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual MeetingYahoo Finance·Dec 3, 2025
All 20 articles loaded
Price Data
Open$9.10
Previous Close$8.92
Day High$9.30
Day Low$8.81
52 Week High$17.19
52 Week Low$0.00
Fundamentals
Market Cap$268M
P/E Ratio—
EPS$-0.98
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume247K
Avg Volume (10D)—
Shares Outstanding27.2M
About Carlsmed Inc
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.
HEALTHCAREHEALTH INFORMATION SERVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICHEALTH INFORMATION SERVICES
CIK—
Composite FIGI—
Share Class FIGI—